Cite
Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis.
MLA
Rodrigo, Juan P., et al. “Tumor Mutational Burden Predictability in Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: Systematic Review and Meta-Analysis.” Journal of Translational Medicine, vol. 22, no. 1, Feb. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12967-024-04937-x.
APA
Rodrigo, J. P., Sánchez-Canteli, M., Otero-Rosales, M., Martínez-Camblor, P., Hermida-Prado, F., & García-Pedrero, J. M. (2024). Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis. Journal of Translational Medicine, 22(1), 1–10. https://doi.org/10.1186/s12967-024-04937-x
Chicago
Rodrigo, Juan P., Mario Sánchez-Canteli, María Otero-Rosales, Pablo Martínez-Camblor, Francisco Hermida-Prado, and Juana M. García-Pedrero. 2024. “Tumor Mutational Burden Predictability in Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: Systematic Review and Meta-Analysis.” Journal of Translational Medicine 22 (1): 1–10. doi:10.1186/s12967-024-04937-x.